Cargando…
Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
Acute pulmonary embolism (PE) is a disease frequently encountered in clinical practice. While the management of haemodynamically stable, low risk patients with acute PE is well established, managing intermediate disease often presents a therapeutic dilemma. In this review, we discuss the various the...
Autores principales: | Bhamani, Amyn, Pepke-Zaba, Joanna, Sheares, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436190/ https://www.ncbi.nlm.nih.gov/pubmed/30984375 http://dx.doi.org/10.12688/f1000research.17861.1 |
Ejemplares similares
-
Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021) -
Successful low-dose thrombolysis of submassive pulmonary embolus in a pregnant patient
por: Dhutia, Harshil, et al.
Publicado: (2014) -
A systematic review for the role of systemic thrombolysis in intermediate-risk (submassive) pulmonary embolism
por: Seif, Mohamed Ahmed
Publicado: (2020) -
Lifting the fog
por: Sukel, Kayt
Publicado: (2022) -
Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism
por: Patel, Darshan C., et al.
Publicado: (2019)